The Cares Act and related federal programs such as the PPP loan program and programs funding Covid-19 laboratory testing laboratories have increasingly been the subject of aggressive government enforcement; and we have the experience to navigate this area.
The Coronavirus Aid, Relief, and Economic Security (CARES) Act provided more than $2 trillion in economic relief to help Americans cope with the economic impact of the COVID-19 global pandemic. The Act originally authorized up to $349 billion in forgivable loans to small businesses through the Paycheck Protection Program (PPP), and Congress later authorized $321 billion in additional PPP funding. Additionally, the CARES Act has authorized other relief, such as the Economic Injury Disaster Loan (EIDL), Health Resources & Services Administration (HRSA) COVID-19 testing for the uninsured, Economic Impact Payments (EIP), Provider Relief Fund (PRF), Pandemic Unemployment Assistance (PUA), and Federal Pandemic Unemployment Compensation (FPUC) and Employee Retention Credit (ERC). Our team of former federal prosecutors and regulatory attorneys provide insight and valuable experience in investigations, defense, regulatory and compliance matters involving the various CARES Act programs.